Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma (MEMMAT)

Clinical Trial ID NCT01356290

PubWeight™ 4.10‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01356290

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol 2013 1.12
3 The rationale for targeted therapies in medulloblastoma. Neuro Oncol 2013 0.92
4 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100